Literature DB >> 19950199

Glycolytic pyruvate regulates P-Glycoprotein expression in multicellular tumor spheroids via modulation of the intracellular redox state.

Maria Wartenberg1, Madeleine Richter, André Datchev, Sebastian Günther, Nada Milosevic, Mohamed M Bekhite, Hans-Reiner Figulla, Josep M Aran, Jordi Pétriz, Heinrich Sauer.   

Abstract

UNLABELLED: ABC transporters like P-glycoprotein (P-gp/ABCB1) are membrane proteins responsible for the transport of toxic compounds out of non-malignant cells and tumor tissue. AIM: To investigate the effect of glycolysis and the tissue redox state on P-gp expression in multicellular tumor spheroids derived from prostate adenocarcinoma cells (DU-145), glioma cells (Gli36), and the human cervix carcinoma cell line KB-3-1 transfected with a P-gp-EGFP fusion gene that allows monitoring of P-gp expression in living cells. During cell culture of DU-145, Gli36, and KB-3-1 tumor spheroids P-gp expression was observed as well as increased lactate and decreased pyruvate levels and expression of glycolytic enzymes. Inhibition of glycolysis for 24 h by either iodoacetate (IA) or 2-deoxy-D-glucose (2-DDG) downregulated P-gp expression which was reversed upon coincubation with the radical scavenger ebselen as shown by semi-quantitative immunohistochemisty in DU-145 and Gli36 tumor spheroids, and by EGFP fluorescence in KB-3-1 tumor spheroids. Consequently endogenous ROS generation in DU-145 tumor spheroids was increased in the presence of either IA or 2-DDG, which was abolished upon coincubation with ebselen. Exogenous addition of pyruvate significantly reduced ROS generation, increased P-gp expression as well as efflux of the P-gp substrate doxorubicin. Doxorubicin transport was significantly blunted by 2-DDG and IA, indicating that inhibition of glycolysis reversed the multidrug resistance phenotype. In summary our data demonstrate that P-gp expression in tumor spheroids is closely related to the glycolytic metabolism of tumor cells and can be downregulated by glycolysis inhibitors via mechanisms that involve changes in the cellular redox state. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19950199     DOI: 10.1002/jcb.22422

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

Review 1.  Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

2.  7-Ketocholesterol induces P-glycoprotein through PI3K/mTOR signaling in hepatoma cells.

Authors:  Sheng-Fan Wang; Yueh-Ching Chou; Nirmal Mazumder; Fu-Jen Kao; Leslie D Nagy; F Peter Guengerich; Cheng Huang; Hsin-Chen Lee; Ping-Shan Lai; Yune-Fang Ueng
Journal:  Biochem Pharmacol       Date:  2013-06-19       Impact factor: 5.858

Review 3.  Drug resistance in glioblastoma: a mini review.

Authors:  Catherine P Haar; Preetha Hebbar; Gerald C Wallace; Arabinda Das; William A Vandergrift; Joshua A Smith; Pierre Giglio; Sunil J Patel; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2012-01-10       Impact factor: 3.996

4.  A Bayesian approach to estimate the diffusion coefficient of Rhodamine 6G in breast cancer spheroids.

Authors:  Miad Boodaghi; Sarah Libring; Luis Solorio; Arezoo M Ardekani
Journal:  J Control Release       Date:  2021-10-09       Impact factor: 9.776

5.  Single cell mass spectrometry studies reveal metabolomic features and potential mechanisms of drug-resistant cancer cell lines.

Authors:  Mei Sun; Xingxiu Chen; Zhibo Yang
Journal:  Anal Chim Acta       Date:  2022-04-01       Impact factor: 6.911

6.  Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin.

Authors:  Diana Tavares-Valente; Fátima Baltazar; Roxana Moreira; Odília Queirós
Journal:  J Bioenerg Biomembr       Date:  2013-06-30       Impact factor: 2.945

7.  HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.

Authors:  Zheyi Hu; Zaigang Zhou; Yahui Hu; Jinhui Wu; Yunman Li; Wenlong Huang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

8.  A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells.

Authors:  Yu-Li Lo
Journal:  Int J Mol Sci       Date:  2012-12-21       Impact factor: 5.923

9.  Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy.

Authors:  J P Golding; T Wardhaugh; L Patrick; M Turner; J B Phillips; J I Bruce; S G Kimani
Journal:  Br J Cancer       Date:  2013-07-16       Impact factor: 7.640

Review 10.  Tumor glycolysis as a target for cancer therapy: progress and prospects.

Authors:  Shanmugasundaram Ganapathy-Kanniappan; Jean-Francois H Geschwind
Journal:  Mol Cancer       Date:  2013-12-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.